147 related articles for article (PubMed ID: 2576594)
1. Complement-dependent cytotoxicity of antibodies reactive with HIV-induced cell surface antigens in HIV-carrying haemophiliacs.
Tóth FD; Kiss J; Szabó B; Füst G; Ujhelyi E; Hollán SR; Váczi L
Acta Virol; 1989 Dec; 33(6):521-6. PubMed ID: 2576594
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and specificity of lymphocytotoxic antibodies in different stages of HIV infection.
Szabó B; Tóth FD; Kiss J; Füst G; Ujhelyi E; Bánhegyi D; Horváth A; Hollán SR
Acta Virol; 1992 Aug; 36(4):392-400. PubMed ID: 1362323
[TBL] [Abstract][Full Text] [Related]
3. Monocytotoxic antibodies in HIV-infected persons. TNF-alpha treatment of U937 cells increases the complement dependent cytotoxicity.
Szabó B; Locardi C; Lo Presti E; Benedetto A; Belardelli F
Acta Microbiol Hung; 1993; 40(3):191-200. PubMed ID: 8191865
[TBL] [Abstract][Full Text] [Related]
4. Anti-class II antibodies in AIDS patients and AIDS-risk groups.
de la Barrera S; Fainboim L; Lugo S; Picchio GR; Muchinik GR; de Bracco MM
Immunology; 1987 Dec; 62(4):599-604. PubMed ID: 3501399
[TBL] [Abstract][Full Text] [Related]
5. Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages.
Ljunggren K; Böttiger B; Biberfeld G; Karlson A; Fenyö EM; Jondal M
J Immunol; 1987 Oct; 139(7):2263-7. PubMed ID: 3498755
[TBL] [Abstract][Full Text] [Related]
6. Activation of complement on the surface of cells infected by human immunodeficiency virus.
Spear GT; Landay AL; Sullivan BL; Dittel B; Lint TF
J Immunol; 1990 Feb; 144(4):1490-6. PubMed ID: 1968081
[TBL] [Abstract][Full Text] [Related]
7. Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus.
Spear GT; Takefman DM; Sullivan BL; Landay AL; Jennings MB; Carlson JR
Virology; 1993 Aug; 195(2):475-80. PubMed ID: 8337824
[TBL] [Abstract][Full Text] [Related]
8. "Anti-platelet antibodies" in HIV infected haemophiliacs.
Fabris F; Cordiano I; Casonato A; Zanon E; Luzzatto G; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(5):709-16. PubMed ID: 1709904
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to human immunodeficiency virus in human sera induce cell-mediated lysis of human immunodeficiency virus-infected cells.
Ojo-Amaize EA; Nishanian P; Keith DE; Houghton RL; Heitjan DF; Fahey JL; Giorgi JV
J Immunol; 1987 Oct; 139(7):2458-63. PubMed ID: 2821115
[TBL] [Abstract][Full Text] [Related]
10. Fc receptor but not complement binding is important in antibody protection against HIV.
Hessell AJ; Hangartner L; Hunter M; Havenith CE; Beurskens FJ; Bakker JM; Lanigan CM; Landucci G; Forthal DN; Parren PW; Marx PA; Burton DR
Nature; 2007 Sep; 449(7158):101-4. PubMed ID: 17805298
[TBL] [Abstract][Full Text] [Related]
11. [Autoantibodies in hemophilia: consequence of HIV-1 infection and/or cofactors in the development of the infection?].
de Elizalde de Bracco MM; Riera N; Galassi N; de la Barrera S; Anselmo A; Pérez Bianco R
Sangre (Barc); 1992 Jun; 37(3):225-36. PubMed ID: 1440104
[No Abstract] [Full Text] [Related]
12. Lymphocyte autoantibodies and alloantibodies in HIV-positive haemophilia patients.
Daniel V; Schimpf K; Opelz G
Clin Exp Immunol; 1989 Feb; 75(2):178-83. PubMed ID: 2784732
[TBL] [Abstract][Full Text] [Related]
13. [Anti-env and anti-gag antibodies in subjects infected with the human immunodeficiency virus].
Sanz del Forcallo FJ; García Delgado R; Ortiz Maslloréns F
Rev Clin Esp; 1989 Dec; 185(9):443-7. PubMed ID: 2696006
[TBL] [Abstract][Full Text] [Related]
14. In vitro immunoglobulin synthesis as a CD4+ lymphocyte depletion predictor in HIV-1-infected asymptomatic haemophiliacs.
Cavallin F; Traldi A; Di Gaetano R; Zambello R
AIDS; 1994 Dec; 8(12):1728-9. PubMed ID: 7888124
[No Abstract] [Full Text] [Related]
15. Tumour necrosis factor-alpha increases the sensitivity of human immunodeficiency virus (HIV)-infected monocytic U937 cells to the complement-dependent cytotoxicity of sera from HIV type 1-infected individuals; role of the gp120 protein.
Szabò B; Locardi C; Lo Presti E; Belardelli F; Benedetto A
J Gen Virol; 1993 Jul; 74 ( Pt 7)():1271-6. PubMed ID: 8336118
[TBL] [Abstract][Full Text] [Related]
16. Biological aspects of HIV infection.
Macchi B; Petruzzelli MA; De Laurenzi V
Clin Ter; 1992 Feb; 140(2):169-77. PubMed ID: 1568358
[TBL] [Abstract][Full Text] [Related]
17. Lysis of cells infected with HIV-1 by human lymphocytes targeted with monoclonal antibody heteroconjugates.
Zarling JM; Moran PA; Grosmaire LS; McClure J; Shriver K; Ledbetter JA
J Immunol; 1988 Apr; 140(8):2609-13. PubMed ID: 2965725
[TBL] [Abstract][Full Text] [Related]
18. An aberrant subclass pattern of HIV-specific immunoglobulin G in sera from haemophiliacs.
Klasse PJ; Berntorp E; Hansson BG
AIDS; 1988 Aug; 2(4):311-3. PubMed ID: 3140836
[TBL] [Abstract][Full Text] [Related]
19. Complement-activating antibodies in sera from infected individuals and vaccinated volunteers that target human immunodeficiency virus type 1 to complement receptor type 1 (CR1, CD35).
Zhou J; Montefiori DC
Virology; 1996 Dec; 226(1):13-21. PubMed ID: 8941318
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to human T cell leukaemia virus-associated membrane antigens in haemophiliacs: evidence for infection before 1980.
Evatt BL; Stein SF; Francis DP; Lawrence DN; McLane MF; McDougal JS; Lee TH; Spira TJ; Cabradilla C; Mullens JI; Essex M
Lancet; 1983 Sep; 2(8352):698-700. PubMed ID: 6136838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
